Functionally, some studies showed that CD4+CD25−FoxP3+T cells have no inhibitory function; others indicated that these cells can inhibit inflammation in immune rejection and autoimmune diseases [24, 25]. This evidence concerns the gene CD4 and autoimmune disease.